These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 18313663

  • 1. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
    Williams J, Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Apr 14; 584(1):78-86. PubMed ID: 18313663
    [Abstract] [Full Text] [Related]

  • 2. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL, Martin ZL, Smith FL, Welch SP.
    J Pharmacol Exp Ther; 1999 May 14; 289(2):859-67. PubMed ID: 10215664
    [Abstract] [Full Text] [Related]

  • 3. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
    Cox ML, Haller VL, Welch SP.
    Eur J Pharmacol; 2007 Jul 12; 567(1-2):125-30. PubMed ID: 17498686
    [Abstract] [Full Text] [Related]

  • 4. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL, Welch SP.
    J Pharmacol Exp Ther; 2003 Jun 12; 305(3):812-7. PubMed ID: 12606610
    [Abstract] [Full Text] [Related]

  • 5. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
    Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G.
    Psychopharmacology (Berl); 2001 Nov 12; 158(3):259-66. PubMed ID: 11713615
    [Abstract] [Full Text] [Related]

  • 6. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
    Williams IJ, Edwards S, Rubo A, Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2006 Jun 06; 539(1-2):57-63. PubMed ID: 16687136
    [Abstract] [Full Text] [Related]

  • 7. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
    Cichewicz DL, McCarthy EA.
    J Pharmacol Exp Ther; 2003 Mar 06; 304(3):1010-5. PubMed ID: 12604676
    [Abstract] [Full Text] [Related]

  • 8. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
    Hernández-Delgadillo GP, Cruz SL.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):54-9. PubMed ID: 16914138
    [Abstract] [Full Text] [Related]

  • 9. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
    Pugh G, Smith PB, Dombrowski DS, Welch SP.
    J Pharmacol Exp Ther; 1996 Nov 28; 279(2):608-16. PubMed ID: 8930163
    [Abstract] [Full Text] [Related]

  • 10. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    Welch SP, Thomas C, Patrick GS.
    J Pharmacol Exp Ther; 1995 Jan 28; 272(1):310-21. PubMed ID: 7815346
    [Abstract] [Full Text] [Related]

  • 11. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
    Bujalska M, Malinowska E, Makulska-Nowak H, Gumułka SW.
    Pharmacology; 2008 Jan 28; 82(3):180-6. PubMed ID: 18701828
    [Abstract] [Full Text] [Related]

  • 12. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA, Selley DE, Sim-Selley LJ, Welch SP.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):129-37. PubMed ID: 17603035
    [Abstract] [Full Text] [Related]

  • 13. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
    Terner JM, Barrett AC, Lomas LM, Negus SS, Picker MJ.
    Pain; 2006 May 01; 122(1-2):90-101. PubMed ID: 16527399
    [Abstract] [Full Text] [Related]

  • 14. Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents.
    Khroyan TV, Polgar WE, Orduna J, Zaveri NT, Judd AK, Tuttle DJ, Sanchez A, Toll L.
    Eur J Pharmacol; 2007 Mar 29; 560(1):29-35. PubMed ID: 17303110
    [Abstract] [Full Text] [Related]

  • 15. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine.
    Cichewicz DL, Haller VL, Welch SP.
    J Pharmacol Exp Ther; 2001 Apr 29; 297(1):121-7. PubMed ID: 11259535
    [Abstract] [Full Text] [Related]

  • 16. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
    Shu H, Hayashida M, Arita H, Huang W, Xiao L, Chiba S, Sekiyama H, Hanaoka K.
    J Ethnopharmacol; 2008 Sep 26; 119(2):276-83. PubMed ID: 18687394
    [Abstract] [Full Text] [Related]

  • 17. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
    Christoph T, De Vry J, Tzschentke TM.
    Neurosci Lett; 2010 Feb 12; 470(2):91-4. PubMed ID: 20026182
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.
    Cichewicz DL, Welch SP, Smith FL.
    Eur J Pharmacol; 2005 Nov 21; 525(1-3):74-82. PubMed ID: 16288738
    [Abstract] [Full Text] [Related]

  • 19. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
    Wakley AA, Craft RM.
    Behav Pharmacol; 2011 Sep 21; 22(5-6):489-97. PubMed ID: 21716095
    [Abstract] [Full Text] [Related]

  • 20. Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast.
    Lilius TO, Rauhala PV, Kambur O, Kalso EA.
    Anesthesiology; 2009 Dec 21; 111(6):1356-64. PubMed ID: 19934882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.